Recruiting studies: Acute Treatment Of Migraine

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults
Phase 2 · 1 location(s) · Sichuan Purity Pharmaceutical Technology Co., Ltd. · NCT07304518 A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
Phase 1 · 13 location(s) · Pfizer · NCT06995729 Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Ch
Phase 3 · 129 location(s) · AbbVie · NCT05125302 Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Phase 3 · 246 location(s) · Pfizer · NCT04649242 Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder De
Phase 2 · 6 location(s) · Aspeya, Inc. · NCT07646613 Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase
Phase N/A · 3 location(s) · AbbVie · NCT07310290 A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
Phase 4 · 7 location(s) · Pfizer · NCT07609914 A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · 115 location(s) · Kallyope Inc. · NCT07645924 Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Phase 3 · 125 location(s) · Pfizer · NCT04743141 i-NEED: NEw migrainE Drugs Database
Phase N/A · 2 location(s) · IRCCS San Raffaele Roma · NCT07103694 Gepant treAtments: EffectIveNess and tolERability (GAINER)
Phase N/A · 2 location(s) · University of Florence · NCT05903027 Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620 Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Me
Phase 4 · 1 location(s) · Mayo Clinic · NCT06401642

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.